original ) (raw )Natriuretic peptide-guided levosimendan therapy for heart failure: A promising new approach
Andreas Kalogeropoulos
International Journal of Cardiology, 2008
View PDFchevron_right
Intermittent levosimendan treatment in patients with severe congestive heart failure
Minna Kurttila
Clinical Research in Cardiology, 2013
View PDFchevron_right
Comparison of single-dose and repeated levosimendan infusion in patients with acute exacerbation of advanced heart failure
Mesut Demir
Medical Science Monitor, 2014
View PDFchevron_right
Efficiency and safety of prolonged levosimendan infusion in patients with acute heart failure
Raimund Erbel
European Journal of Heart Failure Supplements, 2008
View PDFchevron_right
Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period
Juan Delgado
ESC Heart Failure
View PDFchevron_right
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy
Henning Mølgaard
International journal of cardiology, 2017
View PDFchevron_right
Intermittent levosimendan infusions in advanced heart failure: a real world experience
Alessandra Villani
Journal of International Medical Research, 2017
View PDFchevron_right
The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: Clinical implications
Atila Iyisoy
International Journal of Cardiology, 2008
View PDFchevron_right
Repetitive use of levosimendan for treatment of chronic advanced heart failure: Clinical evidence, practical considerations, and perspectives: An expert panel consensus
A. Parkhomenko
International Journal of Cardiology, 2014
View PDFchevron_right
A 6Month Follow-up of Intermittent Levosimendan Administration Effect on Systolic Function, Specific Activity Questionnaire, and Arrhythmia in Advanced Heart Failure
George Athanasopoulos
Journal of Cardiac Failure, 2007
View PDFchevron_right
Multicenter experiences with levosimendan therapy and its safety in patients with decompensated advanced heart failure
Ewa Straburzynska-migaj
Advances in Clinical and Experimental Medicine, 2020
View PDFchevron_right
Haemodynamic effects of levosimendan in advanced but stable chronic heart failure
Aristomenis Manouras
ESC Heart Failure, 2018
View PDFchevron_right
Intermittent Levosimendan Infusions in Advanced Heart Failure
G. Malfatto
Journal of Cardiovascular Pharmacology, 2012
View PDFchevron_right
Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials
Ambra Di Prima
Clinical research in cardiology : official journal of the German Cardiac Society, 2014
View PDFchevron_right
Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application
K. Karason
Cardiovascular Drugs and Therapy
View PDFchevron_right
Use of levosimendan in acute heart failure
Simon Matskeplishvili
European Heart Journal Supplements
View PDFchevron_right
Levosimendan in acute and advanced heart failure
Kristjan Karason
Journal of Cardiovascular Pharmacology
View PDFchevron_right
The potential of the inodilator levosimendan in maintaining quality of life in advanced heart failure
Cândida Fonseca
European Heart Journal Supplements, 2017
View PDFchevron_right
Levosimendan benefits critically ill patients with decompensated heart failure assessed with plasma B-type natriuretic peptide (BNP) and LVEF
Marek Nalos
2003
View PDFchevron_right
European Experience on the Practical Use of Levosimendan in Patients with Acute Heart Failure Syndromes
Ferenc Follath
The American Journal of Cardiology, 2005
View PDFchevron_right
Effects of levosimendan without loading dose on systolic and diastolic function in patients with end-stage heart failure
Elisabetta Palmerini
Cardiology Journal, 2011
View PDFchevron_right
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure
William Smith
View PDFchevron_right
Prognostic value of noninvasive hemodynamic evaluation of the acute effect of levosimendan in advanced heart failure
Alessandra Villani
Journal of Cardiovascular Medicine, 2014
View PDFchevron_right
Levosimendan for the treatment of acute severe heart failure: A meta-analysis of randomised controlled trials
Anthony Delaney
International Journal of Cardiology, 2010
View PDFchevron_right
Levosimendan Administration May Provide More Benefit for Survival in Patients with Non-Ischemic Cardiomyopathy Experiencing Acute Decompensated Heart Failure
Wei-chieh Lee
Journal of Clinical Medicine
View PDFchevron_right